160 related articles for article (PubMed ID: 9526946)
1. Mechanisms involved in the antiplatelet activity of tetramethylpyrazine in human platelets.
Sheu JR; Kan YC; Hung WC; Ko WC; Yen MH
Thromb Res; 1997 Nov; 88(3):259-70. PubMed ID: 9526946
[TBL] [Abstract][Full Text] [Related]
2. The antiplatelet activity of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, is mediated through inhibition of phospholipase C.
Sheu JR; Kan YC; Hung WC; Su CH; Lin CH; Lee YM; Yen MH
Thromb Res; 1998 Oct; 92(2):53-64. PubMed ID: 9792112
[TBL] [Abstract][Full Text] [Related]
3. Mechanism involved in the antiplatelet activity of naloxone in human platelets.
Sheu JR; Hung WC; Lee LW; Chang PT; Kan YC; Yen MH
Biochem Biophys Res Commun; 1997 Feb; 231(1):12-6. PubMed ID: 9070210
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms involved in the antiplatelet activity of midazolam in human platelets.
Sheu JR; Hsiao G; Luk HN; Chen YW; Chen TL; Lee LW; Lin CH; Chou DS
Anesthesiology; 2002 Mar; 96(3):651-8. PubMed ID: 11873041
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of action of a potent antiplatelet peptide, triflavin from Trimeresurus flavoviridis snake venom.
Huang TF; Sheu JR; Teng CM
Thromb Haemost; 1991 Oct; 66(4):489-93. PubMed ID: 1665595
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms involved in the antiplatelet activity of magnesium in human platelets.
Sheu JR; Hsiao G; Shen MY; Fong TH; Chen YW; Lin CH; Chou DS
Br J Haematol; 2002 Dec; 119(4):1033-41. PubMed ID: 12472585
[TBL] [Abstract][Full Text] [Related]
7. Morphine-potentiated agonist-induced platelet aggregation through alpha2-adrenoceptors in human platelets.
Sheu JR; Yeh GC; Fang CL; Lin CH; Hsiao G
J Cardiovasc Pharmacol; 2002 Nov; 40(5):743-50. PubMed ID: 12409983
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet activity of green tea catechins is mediated by inhibition of cytoplasmic calcium increase.
Kang WS; Chung KH; Chung JH; Lee JY; Park JB; Zhang YH; Yoo HS; Yun YP
J Cardiovasc Pharmacol; 2001 Dec; 38(6):875-84. PubMed ID: 11707691
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms involved in the antiplatelet activity of ketamine in human platelets.
Chang Y; Chen TL; Wu GJ; Hsiao G; Shen MY; Lin KH; Chou DS; Lin CH; Sheu JR
J Biomed Sci; 2004; 11(6):764-72. PubMed ID: 15591773
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory mechanisms of metallothionein on platelet aggregation in in vitro and platelet plug formation in in vivo experiments.
Sheu JR; Hsiao G; Shen MY; Wang Y; Lin KH; Lin CH; Chou DS
Exp Biol Med (Maywood); 2003 Dec; 228(11):1321-8. PubMed ID: 14681547
[TBL] [Abstract][Full Text] [Related]
11. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological properties of YM-57029, a novel platelet glycoprotein IIb/IIIa antagonist.
Moritani Y; Sato K; Shigenaga T; Hisamichi N; Ichihara M; Akamatsu S; Suzuki Ki; Nii T; Kaku S; Kawasaki T; Matsumoto Y; Inagaki O; Tomioka K; Yanagisawa I
Eur J Pharmacol; 2002 Mar; 439(1-3):43-52. PubMed ID: 11937091
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms involved in the antiplatelet activity of Escherichia coli lipopolysaccharide in human platelets.
Sheu JR; Hung WC; Kan YC; Lee YM; Yen MH
Br J Haematol; 1998 Oct; 103(1):29-38. PubMed ID: 9792285
[TBL] [Abstract][Full Text] [Related]
14. Specific inhibiting characteristics of tetramethylpyrazine, one of the active ingredients of the Chinese herbal medicine 'Chuanxiong,' on platelet thrombus formation under high shear rates.
Li M; Handa S; Ikeda Y; Goto S
Thromb Res; 2001 Oct; 104(1):15-28. PubMed ID: 11583735
[TBL] [Abstract][Full Text] [Related]
15. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS
J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic and antiplatelet activities of 2-chloro-3-[4-(ethylcarboxy)-phenyl]-amino-1,4-naphthoquinone (NQ12), a newly synthesized 1,4-naphthoquinone derivative.
Yuk DY; Ryu CK; Hong JT; Chung KH; Kang WS; Kim Y; Yoo HS; Lee MK; Lee CK; Yun YP
Biochem Pharmacol; 2000 Oct; 60(7):1001-8. PubMed ID: 10974210
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory mechanisms of naloxone on human platelets.
Sheu JR; Lee YM; Lee LW; Luk HN; Yen MH
Clin Exp Pharmacol Physiol; 1998; 25(7-8):585-91. PubMed ID: 9673433
[TBL] [Abstract][Full Text] [Related]
18. A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom.
Huang TF; Sheu JR; Teng CM
Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):351-7. PubMed ID: 1859363
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory mechanisms of activated matrix metalloproteinase-9 on platelet activation.
Lee YM; Lee JJ; Shen MY; Hsiao G; Sheu JR
Eur J Pharmacol; 2006 May; 537(1-3):52-8. PubMed ID: 16624282
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet activity of L-sulforaphane by regulation of platelet activation factors, glycoprotein IIb/IIIa and thromboxane A2.
Oh CH; Shin JI; Mo SJ; Yun SJ; Kim SH; Rhee YH
Blood Coagul Fibrinolysis; 2013 Jul; 24(5):498-504. PubMed ID: 23412354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
